Inceptionr LLC Alkermes Plc. Transaction History

Inceptionr LLC

  • $410 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$23.21 - $27.24 $522,596 - $613,335
22,516 New
22,516 $543 Million
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $55,997 - $65,890
2,061 Added 20.69%
12,022 $337 Million
Q2 2023

Aug 11, 2023
BUY
$28.34 - $33.63 $282,294 - $334,988
9,961 New
9,961 $312 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email